By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Innovation Pharma (Formerly known as Cellceutix) 

100 Cumming Center, Suite 151-B
Suite A225
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-236-8717 Fax: 978-921-6564


SEARCH JOBS








Company News
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Completes Patient Enrollment In Phase II Study Of Brilacidin For The Prevention Of Severe Oral Mucositis 8/7/2017 11:00:41 AM
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Phase II PoC Trial For Inflammatory Bowel Disease Achieves Induction Of Remission In A Majority Of Patients Treated With Brilacidin 7/14/2017 11:02:23 AM
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Completes Treatments In Phase II PoC Trial For Induction Of Remission In Inflammatory Bowel Disease; Topline Results With Endoscopic Response To Be Presented July 13, 2017 6/26/2017 7:51:57 AM
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Name And Ticker Change Effective, Replay Of Shareholder Conference Call Available 6/9/2017 8:03:47 AM
Cellceutix (CTIX) Announces Company Name Change To Innovation Pharma 6/8/2017 11:10:51 AM
Cellceutix (CTIX) Completes Patient Enrollment Of Final Cohort In Phase II Trial Of Brilacidin For Inflammatory Bowel Disease; Topline Results Anticipated In July 5/18/2017 10:15:03 AM
Cellceutix (CTIX) Provides Corporate Update; Significant Milestones Ahead As Multiple Mid-Phase Clinical Trials Set To Conclude 5/10/2017 8:40:00 AM
Cellceutix (CTIX) Announces Details For Upcoming Investor And Shareholder Presentations 4/20/2017 10:25:34 AM
Cellceutix (CTIX) CEO Discusses Brilacidin Following Interim Trial Results For Treating Oral Mucositis And Inflammatory Bowel Disease 4/10/2017 11:06:10 AM
Cellceutix (CTIX) Takes on Anonymous Blogger, Calls Mako Research's Actions "Criminal" 3/20/2017 6:13:40 AM
12345678910...
//-->